Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites

Reiji Yoshimura,1,* Taro Kishi,2,* Nakao Iwata2 1Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka 8078555, Japan; 2Department of Psychiatry, Fujita Medical University, Toyoake Aichi 4701192, Japan*These authors contributed equally to this workCorresp...

Full description

Bibliographic Details
Main Authors: Yoshimura R, Kishi T, Iwata N
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Online Access:https://www.dovepress.com/plasma-levels-of-il-6-in-patients-with-untreated-major-depressive-diso-peer-reviewed-article-NDT
_version_ 1818682170238042112
author Yoshimura R
Kishi T
Iwata N
author_facet Yoshimura R
Kishi T
Iwata N
author_sort Yoshimura R
collection DOAJ
description Reiji Yoshimura,1,* Taro Kishi,2,* Nakao Iwata2 1Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka 8078555, Japan; 2Department of Psychiatry, Fujita Medical University, Toyoake Aichi 4701192, Japan*These authors contributed equally to this workCorrespondence: Reiji YoshimuraDepartment of Psychiatry, University of Occupational and Environmental Health, Kitakyushu Fukuoka 8078555, JapanTell +81936917253Email yoshi621@med.uoeh-u.ac.jpObjective: IL-6 and catecholamines play roles in the pathophysiology of major depressive disorder (MDD).Aim: The present study investigated associations between plasma IL-6 and plasma catecholamine metabolites in patients with MDD.Participants and methods: A total of 148 patients (male/female 65/83, age 49.5±12.1 years) who met the criteria for MDD based on the Diagnostic and Statistical Manual of Mental Disorders IV and 40 participants as healthy controls (HC; male/female 23/17, age 44.0±10.5 years) were enrolled in the present study. Plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and homovanillic acid (HVA) were analyzed using high-performance liquid chromatography, and plasma IL-6 levels were measured using ELISA.Results: No correlations were observed among plasma IL-6 levels, MHPG levels, and HVA levels in patients with MDD. Plasma IL-6 levels in patients with MDD were significantly higher than in the HC. A positive correlation was found between plasma IL-6 levels and Hamilton Rating Scale for Depression-17 scores.Conclusion: No correlations existed between plasma IL-6 levels and plasma catecholamine metabolite levels in patients with MDD, and the severity of depressive state was related to plasma IL-6 levels in MDD.Keywords: IL-6, 3-methoxy-4-hydroxyphenylglycol, homovanillic acid, major depressive disorder, Hamilton Rating Scale for Depression
first_indexed 2024-12-17T10:14:35Z
format Article
id doaj.art-18f4f185196d4ecbbb069589b685b569
institution Directory Open Access Journal
issn 1178-2021
language English
last_indexed 2024-12-17T10:14:35Z
publishDate 2019-09-01
publisher Dove Medical Press
record_format Article
series Neuropsychiatric Disease and Treatment
spelling doaj.art-18f4f185196d4ecbbb069589b685b5692022-12-21T21:52:57ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212019-09-01Volume 152655266148579Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolitesYoshimura RKishi TIwata NReiji Yoshimura,1,* Taro Kishi,2,* Nakao Iwata2 1Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Fukuoka 8078555, Japan; 2Department of Psychiatry, Fujita Medical University, Toyoake Aichi 4701192, Japan*These authors contributed equally to this workCorrespondence: Reiji YoshimuraDepartment of Psychiatry, University of Occupational and Environmental Health, Kitakyushu Fukuoka 8078555, JapanTell +81936917253Email yoshi621@med.uoeh-u.ac.jpObjective: IL-6 and catecholamines play roles in the pathophysiology of major depressive disorder (MDD).Aim: The present study investigated associations between plasma IL-6 and plasma catecholamine metabolites in patients with MDD.Participants and methods: A total of 148 patients (male/female 65/83, age 49.5±12.1 years) who met the criteria for MDD based on the Diagnostic and Statistical Manual of Mental Disorders IV and 40 participants as healthy controls (HC; male/female 23/17, age 44.0±10.5 years) were enrolled in the present study. Plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and homovanillic acid (HVA) were analyzed using high-performance liquid chromatography, and plasma IL-6 levels were measured using ELISA.Results: No correlations were observed among plasma IL-6 levels, MHPG levels, and HVA levels in patients with MDD. Plasma IL-6 levels in patients with MDD were significantly higher than in the HC. A positive correlation was found between plasma IL-6 levels and Hamilton Rating Scale for Depression-17 scores.Conclusion: No correlations existed between plasma IL-6 levels and plasma catecholamine metabolite levels in patients with MDD, and the severity of depressive state was related to plasma IL-6 levels in MDD.Keywords: IL-6, 3-methoxy-4-hydroxyphenylglycol, homovanillic acid, major depressive disorder, Hamilton Rating Scale for Depressionhttps://www.dovepress.com/plasma-levels-of-il-6-in-patients-with-untreated-major-depressive-diso-peer-reviewed-article-NDTInterleukin-63-methoxy-4-hydroxypheneylglycolhomovanillic acidmajor depressive disorderHamilton Rating Scale for Depression
spellingShingle Yoshimura R
Kishi T
Iwata N
Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
Neuropsychiatric Disease and Treatment
Interleukin-6
3-methoxy-4-hydroxypheneylglycol
homovanillic acid
major depressive disorder
Hamilton Rating Scale for Depression
title Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
title_full Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
title_fullStr Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
title_full_unstemmed Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
title_short Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
title_sort plasma levels of il 6 in patients with untreated major depressive disorder comparison with catecholamine metabolites
topic Interleukin-6
3-methoxy-4-hydroxypheneylglycol
homovanillic acid
major depressive disorder
Hamilton Rating Scale for Depression
url https://www.dovepress.com/plasma-levels-of-il-6-in-patients-with-untreated-major-depressive-diso-peer-reviewed-article-NDT
work_keys_str_mv AT yoshimurar plasmalevelsofil6inpatientswithuntreatedmajordepressivedisordercomparisonwithcatecholaminemetabolites
AT kishit plasmalevelsofil6inpatientswithuntreatedmajordepressivedisordercomparisonwithcatecholaminemetabolites
AT iwatan plasmalevelsofil6inpatientswithuntreatedmajordepressivedisordercomparisonwithcatecholaminemetabolites